GR930300027T1 - - Google Patents

Info

Publication number
GR930300027T1
GR930300027T1 GR930300027T GR930300027T GR930300027T1 GR 930300027 T1 GR930300027 T1 GR 930300027T1 GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T GR930300027 T GR 930300027T GR 930300027 T1 GR930300027 T1 GR 930300027T1
Authority
GR
Greece
Application number
GR930300027T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR930300027T1 publication Critical patent/GR930300027T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GR930300027T 1987-02-27 1993-05-24 GR930300027T1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
GR930300027T1 true GR930300027T1 (https=) 1993-05-24

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930300027T GR930300027T1 (https=) 1987-02-27 1993-05-24

Country Status (26)

Country Link
EP (1) EP0280571B1 (https=)
JP (1) JPH082793B2 (https=)
KR (1) KR960005140B1 (https=)
CN (1) CN1023765C (https=)
AR (1) AR243376A1 (https=)
AT (1) ATE92309T1 (https=)
AU (1) AU604849B2 (https=)
CA (1) CA1316110C (https=)
CY (1) CY1741A (https=)
DE (2) DE3882739T2 (https=)
DK (1) DK175620B1 (https=)
EG (1) EG18523A (https=)
ES (1) ES2044825T3 (https=)
GR (1) GR930300027T1 (https=)
HK (1) HK125793A (https=)
HU (1) HU202747B (https=)
IE (1) IE61419B1 (https=)
IL (1) IL85538A (https=)
LV (1) LV10184B (https=)
MX (1) MX10558A (https=)
NZ (1) NZ223619A (https=)
PH (1) PH24358A (https=)
PT (1) PT86831B (https=)
RU (1) RU1831337C (https=)
UA (1) UA18251A (https=)
ZA (1) ZA881301B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE69131688T2 (de) * 1990-05-04 2000-05-25 Perio Products Ltd., Hahotzvim System zur arzneistoffabgabe im colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CA2174538A1 (en) * 1993-10-22 1995-04-27 Michio Nagasawa Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP3707798B2 (ja) * 1996-05-13 2005-10-19 ノバルティス・コンシューマー・ヘルス・ソシエテ・アノニム 口内薬剤輸送系
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
CA2322432C (en) * 1998-03-03 2005-12-20 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ATE400251T1 (de) * 1999-02-09 2008-07-15 Pfizer Prod Inc Zusammensetzungen basischer arzneistoffe mit verbesserter bioverfügbarkeit
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
DE60034368T2 (de) 1999-12-28 2008-01-03 Kimberly-Clark Worldwide, Inc., Neenah Verwendungs-abhängiges indikatorsystem für absorbierende artikel
US6734157B2 (en) 1999-12-28 2004-05-11 Kimberly-Clark Worldwide, Inc. Controlled release anti-microbial hard surface wiper
BR0016354B1 (pt) 1999-12-28 2012-09-18 método de formação de um pano de limpeza antimicrobiano e pano de limpeza.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
ATE266407T1 (de) * 2000-10-30 2004-05-15 Lupin Ltd Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
EP1589951B1 (en) * 2003-01-03 2017-08-09 Supernus Pharmaceuticals, Inc. Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
CA2669324C (en) * 2006-11-13 2012-06-19 Kyorin Pharmaceutical Co., Ltd. Method for preparing sustained release tablet
CN102438617A (zh) 2009-03-27 2012-05-02 杏林制药株式会社 含有碱性添加剂的基质型缓释制剂
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (https=) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
RU1831337C (ru) 1993-07-30
PT86831A (pt) 1988-03-01
NZ223619A (en) 1990-10-26
MX10558A (es) 1993-11-01
HK125793A (en) 1993-11-19
EP0280571B1 (en) 1993-08-04
AU1219388A (en) 1988-09-01
ZA881301B (en) 1989-10-25
HU202747B (en) 1991-04-29
EP0280571A2 (en) 1988-08-31
PH24358A (en) 1990-06-13
JPH082793B2 (ja) 1996-01-17
EP0280571A3 (en) 1989-01-04
CA1316110C (en) 1993-04-13
DK98088D0 (da) 1988-02-25
ES2044825T1 (es) 1994-01-16
ATE92309T1 (de) 1993-08-15
CN88101062A (zh) 1988-09-07
EG18523A (en) 1993-04-30
IL85538A (en) 1991-09-16
JPS63227519A (ja) 1988-09-21
ES2044825T3 (es) 1994-11-16
IE61419B1 (en) 1994-11-02
KR960005140B1 (ko) 1996-04-22
IE880545L (en) 1988-08-27
PT86831B (pt) 1992-05-29
DE3882739D1 (de) 1993-09-16
LV10184A (lv) 1994-10-20
CY1741A (en) 1995-02-17
LV10184B (en) 1995-04-20
HUT46531A (en) 1988-11-28
DK175620B1 (da) 2004-12-27
DK98088A (da) 1988-08-28
DE280571T1 (de) 1993-08-12
UA18251A (uk) 1997-12-25
IL85538A0 (en) 1988-08-31
KR880009639A (ko) 1988-10-04
AR243376A1 (es) 1993-08-31
CN1023765C (zh) 1994-02-16
DE3882739T2 (de) 1994-02-17
AU604849B2 (en) 1991-01-03

Similar Documents

Publication Publication Date Title
GR930300027T1 (https=)
IN170849B (https=)
IN169580B (https=)
IN171672B (https=)
DE3879938D1 (https=)
IN169637B (https=)
AU7329487A (https=)
AU6957887A (https=)
IN171133B (https=)
AU5857786A (https=)
IN169019B (https=)
IN168537B (https=)
AU7807391A (https=)
AU7737187A (https=)
AU7590587A (https=)
IN167077B (https=)
AU7360487A (https=)
GR3006090T3 (https=)
IN172331B (https=)
AU5977686A (https=)
AU6000786A (https=)
AU6030386A (https=)
AU6641786A (https=)
AU6711487A (https=)
AU6271686A (https=)